Our history
SiCare Bio was launched in late 2024, as a business division of TruTag Technologies, Inc. TruTag is the global leader in the manufacturing of high-precision, bio-compatible nanoporous silica (nPSi) and has dedicated over a decade of research and development to the scalable manufacturing of these materials. TruTag has dedicated over a decade to the scalable manufacture of these materials.
The barriers to replicating this platform are high, driven by an extensive intellectual property portfolio, process trade secrets and proprietary equipment. The nPSi particles were initially designed to add to solid-dose medicines for the purposes of digitizing medicines.
Now, SiCare Bio is building on this manufacturing expertise to offer a novel drug-delivery platform to the pharmaceutical industry.
Executive Team
SiCare Bio is the global leader in the manufacture of high-precision, bio-compatible nanoporous silica (nPSi). Our nPSi particles are highly differentiated vs other forms of mesoporous silica. We have spent over a decade establishing the processes and infrastructure to deliver scalable supply – with capacity to deliver numerous kilograms of nPSi per annum.